Magimairajan I. Vanan
Winnipeg, MB R3E0T4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Proton Beam Therapy for Cancer in Children and Adolescents: A Retrospective Canadian Paediatric Tumour Consortium Study.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: February 05, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2025
Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas.
Journal: Current oncology (Toronto, Ont.)
Published: June 03, 2024
Case report: Slipped capital femoral epiphysis: a rare adverse event associated with FGFR tyrosine kinase inhibitor therapy in a child.
Journal: Frontiers in oncology
Published: March 11, 2024
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Journal: Cancer medicine
Published: November 13, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.
Journal: Cancer discovery
Published: May 15, 2023
Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature.
Journal: Neuro-oncology advances
Published: December 26, 2022
Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 14, 2022
Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT).
Journal: Neuro-oncology advances
Published: August 15, 2022
Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real-world case series.
Journal: Pediatric blood & cancer
Published: January 12, 2022
Last Updated: 09/26/2026